Ekarpen
VC Fund
Bilbao, Spain
Ekarpen is a VC fund in Bilbao focused on Manufacturing and Retail. Ekarpen provides support to innovative sectors with strategic attractiveness.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Ekarpen invests in
Stages Ekarpen invests in
Countries Ekarpen invests in
Round sizes
Round size
- Venture - Series Unknown
- $1.2M–$67M
Investment Focus
Industry
- Manufacturing 2 (22%)
- Retail 1 (11%)
- Battery 1 (11%)
- Shopping 1 (11%)
- Biopharma 1 (11%)
Stage
- Venture - Series Unknown 5 (56%)
- Series A 1 (11%)
- Funding Round 1 (11%)
- Private Equity 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Sherpa.ai
|
Sherpa.ai, based in Bilbao and Silicon Valley, is a leader in Artificial Intelligence services. Among its AI services are the white-label conversational Digital Assistant, predictive technologies, and the most advanced AI framework applied to data privacy in the world. Plus, Sherpa.ai has been named one of the top 10 leading Artificial Intelligencecompanies in the world, alongside Google, Amazon, Microsoft, and IBM. In 2019, Tom Gruber, founder and ex-CTO of Siri, joined the team; and in 2020, marketing executive Joanna Hoffman, the former Marketing Director at Apple, became part of the team, along with Celestino García, the ex-Corporate Vice President of Samsung and current Vice President of Business Development at Sherpa.ai. Sherpa.ai’s Artificial Intelligence platform is designed to improve companies' results. Sherpa.ai has agreements with companies like Porsche, Volkswagen, Prisa, and Samsung, among others. To learn more about Sherpa.ai: http://www.sherpa.ai/ Sherpa Keynote 2020: https://www.youtube.com/watch?v=uPPvTCxg92o Sherpa.ai’s Response to COVID-19: https://www.youtube.com/watch?v=E65xMrrqwFM | $18M / Venture - Series Unknown / Jul 06, 2026 | |
Oncomatryx
|
Oncomatryx is a biopharmaceutical company focused on the tumor microenvironment.Oncomatryx has developed precision drugs and diagnostic devices that target the tumor stroma.Oncomatryx Antibody-Drug Conjugates (ADCs) and human-derived proteins target peritumoral fibroblasts, endothelial cells and extracellular matrix that promote tumorinvasiveness, drug resistance and immunosuppression.Oncomatryx ADCs bear novel proprietary payloads and linker derivatives that render an optimal therapeutic index against pancreatic cancer in vivo. Oncomatryx OMTX705, an ADC which targets cancer-associated fibroblasts (CAFs), inhibits pancreatic tumor growth in patient-derived xenograft mice, both as single agent and in combination with chemotherapy. | $67.3M / Venture - Series Unknown / Mar 23, 2026 | |
Lookiero Outfittery Group
|
Lookiero Outfittery Group is an online personal shopping company. | $19.8M / Venture - Series Unknown / Jan 08, 2026 | |
Basquevolt
|
Basquevolt is a leader in solid state battery technology. | $10.9M / Venture - Series Unknown / Mar 14, 2025 | |
Begas Motor
|
Begas has designed and manufactures the first engine for industrial vehicles powered 100% by LPG (Liquefied Petroleum Gas or AUTOGAS). Ability to remotorize vehicles and make them ecological with Euro VI certificate. | $18.6M / Private Equity / Feb 03, 2025 | |
|
Begas Motor
|
Begas has designed and manufactures the first engine for industrial vehicles powered 100% by LPG (Liquefied Petroleum Gas or AUTOGAS). Ability to remotorize vehicles and make them ecological with Euro VI certificate. | $18.6M / Feb 03, 2025 | |
|
Begas Motor
|
Begas has designed and manufactures the first engine for industrial vehicles powered 100% by LPG (Liquefied Petroleum Gas or AUTOGAS). Ability to remotorize vehicles and make them ecological with Euro VI certificate. | Venture - Series Unknown / Mar 13, 2024 | |
|
Begas Motor
|
Begas has designed and manufactures the first engine for industrial vehicles powered 100% by LPG (Liquefied Petroleum Gas or AUTOGAS). Ability to remotorize vehicles and make them ecological with Euro VI certificate. | $1.2M / Venture - Series Unknown / Sep 01, 2021 | |
|
Sherpa.ai
|
Sherpa.ai, based in Bilbao and Silicon Valley, is a leader in Artificial Intelligence services. Among its AI services are the white-label conversational Digital Assistant, predictive technologies, and the most advanced AI framework applied to data privacy in the world. Plus, Sherpa.ai has been named one of the top 10 leading Artificial Intelligencecompanies in the world, alongside Google, Amazon, Microsoft, and IBM. In 2019, Tom Gruber, founder and ex-CTO of Siri, joined the team; and in 2020, marketing executive Joanna Hoffman, the former Marketing Director at Apple, became part of the team, along with Celestino García, the ex-Corporate Vice President of Samsung and current Vice President of Business Development at Sherpa.ai. Sherpa.ai’s Artificial Intelligence platform is designed to improve companies' results. Sherpa.ai has agreements with companies like Porsche, Volkswagen, Prisa, and Samsung, among others. To learn more about Sherpa.ai: http://www.sherpa.ai/ Sherpa Keynote 2020: https://www.youtube.com/watch?v=uPPvTCxg92o Sherpa.ai’s Response to COVID-19: https://www.youtube.com/watch?v=E65xMrrqwFM | $10M / Series A / Mar 16, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Ekarpen invest in?
Ekarpen invests primarily in Manufacturing, Retail and Battery startups, most often at Venture - Series Unknown and Series A stage. Most of the 9 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Ekarpen's check size?
Ekarpen typically joins rounds of $1.2M–$67M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Ekarpen participates in.
When did Ekarpen last invest?
The most recent investment recorded for Ekarpen closed in Jul 2026. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
